Regulatory Focus™ > News Articles > MHRA Advises Surgeons Against Using Some Metal-on-Metal Hip Implants

MHRA Advises Surgeons Against Using Some Metal-on-Metal Hip Implants

Posted 02 April 2012 | By Alexander Gaffney, RAC 

The Medicines and Healthcare Products Regulatory Agency (MHRA) today (2 April) announced it is recommending surgeons "stop using a particular combination of metal-on-metal total hip replacements because it has a high revision rate compared with other implants."

The implant combination-Mitch TRH cup/heads, made by Finsbury Orthopaedics, used in combination with Accolade femoral stems made by Stryker Orthopaedics-is associated with an "unacceptably high revision rate of 10.7 percent after four years of implantation," wrote MHRA in a statement.

"Analysis has shown that the revision rate for this combination of implant is unacceptably high," said Susanne Ludgate, clinical director of MHRA. "This is why we have advised surgeons to stop using this combination and to monitor their patients closely.

MHRA is also advising surgeons to schedule follow-up appointments with patients for the life of the implant to mitigate any future problems.

Read more:

MHRA - MHRA issues new advice to surgeons about metal-on-metal total hip replacements

Medical Device Alert: Metal-on-metal (MoM) total hip replacements (MDA/2012/016)

Regulatory Focus newsletters

All the biggest regulatory news and happenings.